Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$484.20.8%
Market Cap$124.7B
(15.0%)
Industry median - (44.8%)
5Y Historical average - 50.0%
(22.6%)
Industry median - (37.1%)
5Y Historical average - 44.0%
(3.3%)
Industry median - (37.3%)
5Y Historical average - 21.2%
(5.5%)
Industry median - (40.3%)
5Y Historical average - 17.2%
VRTX Capital Allocation Rating
Crunching data... Almost there!
VRTX Capital Allocation metrics
Crunching data... Almost there!
Competing with VRTX Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Vertex Pharmaceuticals Incorporated (VRTX) ROIC (Return on Invested Capital)?
The Vertex Pharmaceuticals Incorporated (VRTX) ROIC is (15.0%), compared to the industry median of ((44.8%)) and the 5-year historical average of 50.0%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) ROIC minus WACC (Weighted Average Cost of Capital)?
The Vertex Pharmaceuticals Incorporated (VRTX) ROIC minus WACC is (22.6%), compared to the industry median of ((37.1%)) and the 5-year historical average of 44.0%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) ROE (Return on Equity)?
The Vertex Pharmaceuticals Incorporated (VRTX) ROE is (3.3%), compared to the industry median of ((37.3%)) and the 5-year historical average of 21.2%.
What is the Vertex Pharmaceuticals Incorporated (VRTX) ROCE (Return on Capital Employed)?
The Vertex Pharmaceuticals Incorporated (VRTX) ROCE is (5.5%), compared to the industry median of ((40.3%)) and the 5-year historical average of 17.2%.